Skip To Main Content
Quentin M Anstee on Muck Rack

Quentin M Anstee

Newcastle upon Tyne
As seen in: Color Research & Application, Nature, Wiley Online Library, Frontline Gastroenterology, Gut Journal, MDPI, Cell Metabolism, BJGP (British Journal of General Practice), Gastroenterology, Journal Of Hepatology EU and
Professor of Experimental Hepatology & Consultant Hepatologist: NAFLD/MASLD Treatment | Biomarkers | Pathogenesis | Genetics
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Quentin M

Contact Quentin M, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study

|
By Michael Pavlides, Yasaman Vali, Ferenc E. Mozes, Salma Akhtar, Paul Hockings, Elizabeth Shumbayawonda, Kay Pepin, Isabel Fernández-Lizaranzu, Diana Julie Leeming, Jeremy Cobbold, Michael Allison Verified, Guruprasad P. Aithal, Manuel Romero-Gomez, Rocio Aller, Juan M. Pericàs, Jérôme Boursier, Salvatore Petta, Jörn M. Schattenberg, Mattias Ekstedt, Annalisa Berzigotti, Hannele Yki-Jarvinen, Miljen Martic, Clifford A Brass, Michael Kalutkiewicz, Rajarshi Banerjee, Richard L. Ehman, Moritz J. Schneider, Dina Tiniakos, Morten Asser Karsdal, Céline Fournier-Poizat, Vlad Ratziu, Carla Yunis, Elisabetta Bugianesi, Stephen Harrison, Patrick M. Bossuyt, Quentin M Anstee, Kristy Wonders, Theresa Tuthill, Jeremy Magnanensi
| Nature Verified
Abstract There is a need for robust evaluations of noninvasive biomarkers for metabolic dysfunction-associated steatotic liver disease.
Open in Who Shared Issue with article?

A data-driven framework reconstructs the molecular continuum of human MASLD progression

|
By Ioannis Kamzolas, Thodoris Koutsandreas, Charlie Barker, Anna Vathrakokoili Pournara, Naoto Fujiwara, Yujin Hoshida, Quentin M Anstee, Michele Vacca, Irene Papatheodorou, Antonio Vidal-Puig, Evangelia Petsalaki, Harry Weston
| Nature Verified
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) progresses along a continuum from simple steatosis to steatohepatitis, fibrosis, cirrhosis and hepatocellular carcinoma. However, current clinical and research frameworks rely primarily on static, histology-defined stages that fail to capture the continuous nature of disease progression.
Open in Who Shared Issue with article?

Food Insecurity Is Highly Prevalent Amongst Patients With Chronic Liver Disease in Northern England: A Cross‐Sectional Analysis

|
By Rachel Howarth, Stuart McPherson, Quentin M Anstee, Thomas Crame
| Wiley Online Library Verified
1 Introduction Liver disease is the third leading cause of death in the United Kingdom (UK), with mortality rates having increased by 400% since 1970 [1]. This rising burden parallels the increase in excess alcohol consumption, obesity, and viral hepatitis [1]. Liver disorders disproportionately affect the most economically disadvantaged, exacerbating health inequalities [2].
Open in Who Shared Issue with article?
See all 39 licensed articles (40 Total)